| FIRST AUTHOR INDEX |
| First Name |
Last Name |
No. |
Title |
| Philip |
D. Harvey |
SL-1 |
Assessment and treatment of cognition and disability across psychiatric conditions |
| W. Wolfgang |
Fleischhacker |
SL-2 |
Pharmacological treatment of schizophrenia: Current issues and future perspectives |
| Hiroyuki |
Uchida |
S8-4 |
Antipsychotic dose and cognitive impairment |
| Tsuyoshi |
Miyaoka |
PJ-2 |
Efficacy and safety of Yokukansan in treatment-resistant schizophrenia: A Randomized, double-blind, placebo-controlled trial (A positive and negative syndrome scale, five-factor analysis) |
| Takashi |
Tsuboi |
EN-1 |
Challenging the need for sustained blockade of dopamine D2 receptor estimated from antipsychotic plasma levels in the maintenance treatment of schizophrenia: A Single-blind, randomized, controlled study |
| Tetsu |
Tomita |
EN-2 |
The Influence of 5-HTTLPR genotype on the association between the plasma concentration and therapeutic effect of paroxetine in patients with major depressive disorder |
| Fumihiko |
Ueno |
EN-3 |
Whether to increase or maintain dosage of mirtazapine in early nonimprovers with depression |
| W. Wolfgang |
Fleischhacker |
LS3 |
The management of adherence problems and the role of long-acting antipsychotics in the long-term treatment of schizophrenia |
| Philip |
D. Harvey |
LS5 |
Motivation and cognition in schizophrenia: Outcome and treatment implications |
| Hitoshi |
Sakurai |
O1A-1 |
Increasing Versus Maintaining the Dose of Olanzapine or Risperidone for Schizophrenia Patients Who Did Not Respond to Modest Dosage: A Double-Blind Randomized Controlled Trial |
| Takeo |
Saito |
O1A-5 |
Pharmacogenomic study of clozapine-induced agranulocytosis/granulocytopenia in a Japanese population |
| Norio |
Furukori |
O1B-3 |
Characteristics of escitalopram discontinuation syndrome: a preliminary study |
| Kazunari |
Yoshida |
O2C-6 |
Presence/absence of early improvement to antipsychotic treatment predicts subsequent treatment response/non-response in behavioral and psychological symptoms with dementia: Analysis of the CATIE-AD data |
| Shigeru |
Toki |
O2C-7 |
Big five personality, BIS and BAS as predictors for escitalopram treatment in patients with major depression |
| Miho |
Ota |
O2D-2 |
The effects of adjunctive intranasal oxytocin in patients with schizophrenia |
| Jyunichi |
Iga |
O2D-4 |
Association study of polymorphism in the serotonin transporter gene promoter, methylation profiles, and expression in patients with major depressive disorder |
| Nobutomo |
Yamamoto |
P1A-2 |
Inter-rater reliability and concurrent validity of the personal and social performance scale, Japanese version |
| Philip |
D. Harvey |
P1C-3 |
Dose effects for lurasidone treatment of cognitive impairments in schizophrenia |
| Cynthia |
O. Siu |
P1C-4 |
Long-term effects on daytime sleepiness and cognitive function in a 6-month, double-blind study of lurasidone and quetiapine XR in patients with schizophrenia |
| Hikaru |
Hori |
P1D-2 |
Hiccups associated with switching fron olanzapine to aripiprazole in a patient with schizophrenia |
| Takashi |
Watanabe |
P1E-4 |
Impact of CYP2D6*10 polymorphism on the pharmacokinetics of mirtazapine and its desmethylated metabolite in Japanese patients treated with mirtazapine |
| Mitsuhiro |
Tada |
P1E-5 |
Antidepressant dose and treatment response in bipolar depression: Reanalysis of the systematic treatment enhancement program for bipolar disorder (STEP-BD) data |
| Masaaki |
Ogasa |
P1F-3 |
Treatment of depressive symptoms and improved functioning in schizophrenia |
| Yoshiteru |
Takekita |
P1F-5 |
Risperidone long-acting injection versus paliperidone palmitate for cognitive function in Japanese schizophrenia: a 6-month, open-label, randomized, pilot trial. |
| Yoshiteru |
Takekita |
P2C-2 |
Effect of the HTR7 polymorphisms on perospirone and aripiprazole efficacy for Japanese schizophrenia patients |
| Itaru |
Miura |
P2C-4 |
Influence of -141C Ins/Del polymorphism in DRD2 gene on clinical symptoms and plasma homovanillic acid levels in the treatment of schizophrenia with aripiprazole |
